Daniel Moro Quesada

Mapa mental elaborado con @PLAUDAI

@amartinezrubio when to use NT-proBNP in DM?. @ISCPcardio

Mind map by @PLAUDAI

CKD screening: how, when and to whom @A_Ribasclo @ISCPcardio

@Jessica_Ares_B @PLAUDAI Es un dispositivo que ahorra y simplifica mucho el trabajo, te lo recomiendo amzn.eu/d/0EjjZMR

@danielmoro10 @PLAUDAI Jajajajja ojo muy bien resumido😂😂

@Jessica_Ares_B exposes a national survey in secondary prevention. @ISCPcardio

Mapa mental con @PLAUDAI

Finerenone: a new cardiorenal protector that claims its space @EmiliSanAlv @ISCPcardio

Mind map by @PLAUDAI

Wine consumption and Mediterranean diet. The key for longevity in Spain? @MAM_UNAV @ISCPcardio

Mapa mental elaborado con @PLAUDAI

Advances in hypertrophic cardiomyopathy therapy @RebecaLorcaG @ISCPcardio

Mapa mental elaborado con @PLAUDAI

Clinical implications of albuminuria @DrAmodeo @ISCPcardio

Non-pharmacological approaches for stroke-risk reduction @Raqueldvfg @ISCPcardio

Early rhythm control: dream or reality @DavidCalvo307 @ISCPcardio

Are AADs obsolete in the ablation era? @Mallofre_N @ISCPcardio

Challenges in stroke prevention: The role of factor XI inhibitors MD Víctor García @ISCPcardio

How to improve drug adherence and treatment persistence @IvanMaray @ISCPcardio

Socioeconomic aspects and drug adherence and persistence @amartinezrubio @ISCPcardio

Advances in Fabry-Anderson disease by Ana Fidalgo @ISCPcardio

Amyloidosis therapy @basurto_mayte @ISCPcardio

Advances in microcirculation therapy. @jckaski @ISCPcardio